https://www.selleckchem.com/pr....oducts/alofanib-rpt8
1 criteria. Patients with no residual disease were classified as Complete responders (CR) and with residual or progressive disease were classified as Nonresponders (NR). Results were statistically analyzed using Mann Whiney U test to examine significant difference between the expression of microRNA between complete responders (CR) and nonresponders (NR). microRNA-100 5p was upregulated in complete responders (CR) which showed a trend towards statistical significance (p value=0.05). microRNA-100 5p can serve as a potential molecu